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Abstract 
Karlström, Å. 2005. Collagen-like proteins in horse pathogenic Streptococcus equi 
Doctoral dissertation 
ISSN 1652-6880, ISBN 91-576-6998-8 
 
Streptococcus equi subspecies equi is the causative agent of strangles, a respiratory disease 
that affects horses worldwide. Like other pathogenic bacteria, S. equi subspecies  equi 
expresses a number of extracellular proteins important for the interaction with the host and 
thus for the pathogenesis. 
In this thesis, one aim was to identify and characterise novel extracellular proteins in this 
subspecies. Signal phage display was used to screen the genome of S. equi subsp. equi 
strain 1866 for signal sequences thereby identifying extracellular proteins. A novel 
collagen-like protein, SclC, was found and further characterised. The SclC protein, similar 
to Scl proteins in S. pyogenes, has an N-terminal signal sequence, a unique region, a 
collagen-like region and a wall-spanning region ending with an LPXTG-motif preceding 
the membrane-bound region in the C-terminal end. Using bioinformatic tools, the collagen-
like protein was found to be a member of a family consisting of seven collagen-like 
proteins, called SclC-SclI, in subspecies equi. In contrast to mammalian collagen, all these 
proteins have collagen-like regions that consist of KGD/KGE triplets, which are suggested 
to be of importance for the structure of the proteins. 
When sera from horses previously infected with subsp. equi and sera from healthy horses 
were analysed, antibodies against all seven proteins were detected. Furthermore, antibodies 
against SclC recognised all members of the family of collagen-like proteins. In an 
immunisation study in a strangles model in mice, immunisation with SclC resulted in 
protection against infection by S. equi subsp. equi. The biological role of SclC was further 
investigated in a collagen lattice gel contraction study to investigate whether mammalian 
integrins would recognise SclC, which turned out not to be the case. 
The biological role of the collagen-like proteins identified here is not fully comprehended. 
However, since the vaccination studies in mice resulted in protection against infection, 
these proteins have an interesting potential for further vaccine trials in horses. 
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Abbreviations 
α2-M  α2-macroglobulin 
CL collagen-like  region 
CNE  collagen-binding protein in S. equi 
EAG  α2-macroglobulin-, albumin-, IgG-binding protein in S. equi 
subsp. equi 
ECM extracellular  matrix 
ELISA  Enzyme-Linked ImmunoSorbent Assay 
ER endoplasmatic  reticulum 
EtxB  recombinant B-subunit of E. coli enterotoxin 
FN fibronectin 
FNE  fibronectin-binding protein from S. equi subsp. equi 
FNEB  fibronectin-binding protein B in S. equi subsp. equi 
FNZ  fibronectin- and collagen-binding protein from S. equi 
subsp. zooepidemicus 
GAG glycosaminoglycan 
GAS  Group A Streptococci 
Hyp hydroxyproline 
i.n. intranasally 
ISCOM  immune stimulating complex 
ORF  open reading frame 
PDGF  platelet derived growth factor 
s.c. subcutaneously 
Scl  streptococcal collagen-like protein 
SclC streptococcal  collagen-like  protein in Group C streptococcus 
SFS secreted  fibronectin-binding protein in S. equi subsp. equi 
subsp. subspecies  
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"It has long been an axiom of mine that the 
little things are infinitely the most important" 
Sir Arthur Conan Doyle 
 
 
General background 
The state of health is the result of a constant ongoing battle between pathogenic 
microbes and the immune system of the host. Failure of the immune system most 
likely causes the host to turn from healthy to ill and the microbes possess the 
ability to break the defences in more ways than one. Obligate pathogenic bacteria 
are harmful and always cause disease, whereas opportunistic bacteria cause 
disease when the immune system is somewhat compromised. The pathogenic 
bacteria have several ways of deceiving the immune system and overcoming the 
defence mechanisms of the body. One strategy is to cover themselves in structures 
that look familiar to the host system and the pathogens are therefore not 
recognised, another is to have a fast entry phase in which they quickly disappear 
into the host cells, where they are not recognised and detected. The immune 
system, on the other hand, has its own strategies working to investigate all 
unknown agents that are discovered inside the body. 
 
Vaccination is the concept of a vaccine protecting the host against a particular 
microbe (Casadevall & Pirofski, 2004). An antigen is introduced to the immune 
system, which reacts to it, forming antibodies that recognise the antigen. The 
purpose then is for specific antibody production to be activated the next time the 
immune system encounters the antigen. The main problem is to find the right 
antigens that give sufficient protection from the infective agent. Several vaccines 
consist of attenuated strains of bacteria, which are not as pathogenic as the wild 
type bacteria but still share many common features with the actual pathogenic 
agent. In this study, the horse is the host and the infectious agent is represented by 
Streptococcus equi. 
 
Strangles 
Strangles is a disease that affects horses caused by the bacterium 
Streptococcus equi subsp. equi. The disease is spread worldwide and the classic 
description of strangles includes swelling and infection of the throat region, 
although the symptoms can vary from case to case (Harrington, Sutcliffe & 
Chanter, 2002). In uncomplicated cases the disease is localised to the upper 
respiratory tract together with fever, coughing, pus discharge from the nostrils and 
abscess formation in the lymph glands. In more severe cases, when the bacteria are 
found in the lower respiratory tract, pneumonia and heart muscle inflammation can   10
be further complications. Although strangles is not primarily a fatal disease, it can 
cause chronic illness and sometimes death (Timoney, 1988, Timoney, 2004). In 
Sweden, the number of reported cases has decreased from 116 in 2001 to 63 in 
2003 (Jordbruksverket, 2005). However, it is important to remember that this is 
the number of stables and not actual infected individuals. 
 
Streptococcus equi subsp. equi enters the horse via the mouth or nose and the 
bacteria are transported to the lymphoid glands through the mucosal layer. In the 
glands the bacteria form long chains of cocci. The incubation time for the disease 
varies from 3 to 14 days. The normal temperature of a horse ranges between 
37.5°C and 38.5°C but during the disease the temperature may increase to above 
39°C. During the incubation time, the infected horse is highly contagious, which is 
one of the reasons why stables in Sweden where an infected horse is found are 
placed in quarantine for at least 30 days. With the increased temperature comes 
formation of abscesses in lymph glands, followed by a slight cough and 
difficulties in swallowing. As the disease progresses the abscesses can grow hard 
and painful and the pressure on the retropharyngeal lymph nodes can cause 
respiratory difficulties, as the name of the disease indicates. In severe cases, the 
bacteria move into the lower respiratory tract and may cause pneumonia. In horses 
with the most severe form of strangles, any part of the body or viscera may be 
affected, including the heart, and then the disease is called bastard strangles 
(Timoney, 1993, Timoney, 2004). 
 
The disease is most commonly transmitted through infective secretions. Once 
the disease establishes itself on a farm or ranch, it often becomes a persistent and 
recurring problem, even though there may be long periods when no resident horse 
has typical signs of the disease. Once the organism establishes itself in a 
susceptible population, the percentage of animals affected is generally quite high 
and often approaches 100%. However, the mortality rate in most uncomplicated 
cases is low. If the disease is discovered early, it can be treated with penicillin 
although often even that is not necessary as long as the horse has an appetite and 
not too high a fever. 
 
The genus Streptococcus 
Streptococcus  is described in Bergey’s Manual (Hardie, 1986) as spherical or 
sometimes ovoid shaped cells, Gram-positive cocci, catalase negative bacteria that 
usually are facultative anaerobes. They grow in pairs or chains and their 
temperature optimum is usually 37°C, even though minimum and maximum 
temperatures vary within the genus. Not all species form capsules, but it is not 
uncommon. Streptococci are responsible for a large number of important diseases 
in man and in animals. They are found on mucosal membranes of the mouth, 
respiratory and genitourinary tracts, as well as on the skin. The pyogenic group 
(Table 1) are regarded as pathogenic or opportunistic pathogens of mammals 
(Hardie & Whiley, 1995). The most studied member of the pyogenic group is 
Streptococcus pyogenes, belonging to the Lancefield serological group A 
streptococci. It is the causative agent of various diseases in humans, ranging from 
mild infections of the skin area to more severe diseases such as scarlet fever. The 
streptococci can be divided into groups in different ways, e.g. the Lancefield   11
grouping based on differences in serological types devised by Lancefield 
(Lancefield, 1933), their type of haemolysis or their genetic similarity. The genus 
has gone through several revisions regarding taxonomy and nomenclature through 
the last twenty years, as reviewed by Facklam (Facklam, 2002). 
 
Table 1. The pyogenic group in streptococci 
 
Species Lancefield 
group
Haemolysis Host
S. pyogenes  A beta humans
S. agalactiae  B beta humans, cattle
S. dysgalactiae 
    subsp. equisimilis  A/C/G/L alpha/beta humans
    subsp. dysgalactiae  C none cattle
S. equi 
    subsp. equi  C beta horses
    subsp. ruminatorum  C beta sheep
    subsp. zooepdemicus  C beta mammals
S. canis  G beta dogs
S. iniae  none alpha/beta dolphins
S. parauberis  E/P alpha cattle
S. porcinus   E/P/U/V beta pigs
S. uberis  E/P/G alpha/gamma cattle
 
Streptococcus equi 
Three subspecies of Streptococcus equi 
Streptococcus equi is β-haemolytic, belongs to the Lancefield group C 
streptococci and comprises three subspecies, subsp.  equi, subsp.  zooepidemicus 
and subsp. ruminatorum (Hardie & Whiley, 1995, Fernandez et al., 2004). The 
cells are 0.6-1.0 µm in diameter and capsules are demonstrated in some strains 
either when young cultures are examined or when serum is added to the growth 
medium.  
 
S. equi subsp. zooepidemicus is a mucosal commensal in horses and does not 
normally cause disease in healthy horses, although the bacterium is regarded as an 
important opportunistic pathogen (Timoney, 2004). The organism is found in the 
respiratory region, the uterus and wounds, where it occasionally may give rise to 
an infection. This subspecies has also been isolated from humans, as well as from 
a number of mammals including rats, pigs, cats, cattle and mice (Ruoff, 1992). 
 
In contrast, S. equi subsp. equi is an obligate pathogen and is considered to be a 
parasite in the upper respiratory tract of horses (equimilius). Since donkeys and 
mules belong to the same taxonomic group (Equidae), they can also be infected 
(Harrington, Sutcliffe & Chanter, 2002). The bacteria cause strangles, a worldwide 
disease that gives rise to a pathogenic colonisation in the upper respiratory tract 
and affects the animal in various ways. The genome is approximately 2.3 Mb with 
a G+C content of approximately 41%.   12
 
Subsp. rumatorium was only recently described and has been isolated from 
sheep (Fernandez et al., 2004). Even though it has not been defined as a horse 
pathogen, investigations have revealed genetic similarities, placing it as a 
Streptococcus equi subspecies. Since this subspecies has not been identified as a 
horse pathogen, it is not further discussed in this thesis. 
 
Potential virulence factors of Streptococcus equi 
The pathogenicity of different streptococci varies between different species and 
subspecies. Most of the streptococci belonging to the pyogenic  group are 
considered pathogens. Pathogenic streptococci express a number of different 
components in order to establish infections in their host. Of these, some are 
secreted into the growth medium whereas others are associated with the cell wall 
and include factors such as a capsule, various cell surface-anchored proteins, 
secreted enzymes and toxins. In certain species of streptococci, several of these 
types of components have been identified as virulence factors (Lukomski et al., 
1997, Hytonen et al., 2001, Beckmann et al., 2002, Chhatwal, 2002, Batzloff et 
al., 2004). In particular, extracellular enzymes causing disruption of tissue and 
cleavage of host proteins have been noted to have an effect on virulence. Since 
S. equi has been less studied than some of the pyogenic species that affect humans, 
all extracellular components identified have not been confirmed as virulence 
factors. However, many of these proteins share features with the previously 
reported components in e.g.  S. pyogenes, which makes further analysis to 
determine their role in virulence of S. equi interesting. 
 
Capsule 
The capsule, consisting of the polysaccharide hyaluron (formerly called hyaluronic 
acid), may not be present in all pathogenic species (Ruoff, 1992). The capsule in 
itself can be considered to hide the bacteria from discovery by the immune system 
of the host. The capsule does not elicit an immune response in the host due to the 
fact that it is comprised of hyaluron, found naturally in mammals. Furthermore the 
capsule makes it harder for the macrophages to adhere to the bacteria, thus 
creating a bacterium that is more virulent than non-encapsulated bacteria 
(Wibawan et al., 1999). Expression of the capsule has been identified in most of 
the strains investigated in subsp.  equi  but has been found to vary in the less 
virulent subsp. zooepidemicus. 
 
Extracellular proteins 
Many of the cell surface-anchored proteins in Gram-positive bacteria such as 
streptococci display a common structural organisation and features that are 
important in binding the protein to the cell wall (Navarre & Schneewind, 1999). 
The motifs are: an N-terminal signal sequence, which directs the secretion through 
the cell membrane, and a hydrophobic C-terminal domain preceded by an LPXTG 
motif. All these motifs are essential in the protein/cell wall linkage process. 
Examples of host proteins that streptococcal cells can bind via their cell surface 
proteins to their surface include IgG, α2-macroglobulin, serum albumin, 
fibronectin, fibrinogen and collagen (Table 2). In addition the bacteria can secret   13
proteins that have other activities and of which some are considered to affect the 
virulence,  e.g. haemolysins (Flanagan et al., 1998), hyaluronidase (Woischnik, 
Buttaro & Podbielski, 2000), proteinases (Rasmussen, Muller & Bjorck, 1999, von 
Pawel-Rammingen, Johansson & Bjorck, 2002) and streptolysins (Kehoe et al., 
1987, Okumura et al., 1994, Navarre & Schneewind, 1999, Sierig et al., 2003). 
The relative importance of the various potential virulence factors between species 
and sites is likely to vary. 
 
The first reported cell surface protein from S. equi was the M-protein (SeM), 
which was described in the 1980s by Srivastava et al. (Srivastava, Barnum & 
Prescott, 1985). The M-protein is a fibrinogen-binding protein and most 
importantly it is opsonogenic when introduced into a host. Binding of fibrinogen 
has been reported to have an antiphagocytic property and the binding of fibrinogen 
to the S. pyogenes cell surface leads to resistance to phagocytosis by neutrophils 
(Boschwitz & Timoney, 1994). It has also been shown that binding of fibrinogen 
to the subsp. equi surface is partly due to the protein SeM.  
 
The horse pathogenic subspecies of S. equi differ in expression of M-like 
proteins, as subsp. equi have been found to express two (SeM and SzPSe) whereas 
subsp. zooepidemicus only have the homologue to SzPSe (SzP) (Timoney et al., 
1995, Timoney, Artiushin & Boschwitz, 1997, Meehan, Nowlan & Owen, 1998). 
The SeM protein is only opsonogenic in subsp.  equi and not in 
subsp. zooepidemicus. Furthermore, M-like proteins have been reported in other 
streptococci (Schnitzler et al., 1995, Cedervall, Johansson & Åkerström, 1997, 
Geyera et al., 1999, Vasi et al., 2000) and especially in S. pyogenes (Fagan et al., 
2001). In these species there are several different variants of M-like proteins that 
vary between the strains, thus making them important for serotype and strain 
classification. 
 
After the report on the M-protein, several more cell surface and secreted 
proteins from subsp. equi have been identified. Another large group of these 
extracellular proteins are the fibronectin-binding proteins. These proteins consist 
of not only cell wall-bound proteins, FNEB (Lannergard et al., in press), but also 
secreted proteins, SFS (Lindmark & Guss, 1999) and FNE (Lindmark, Nilsson & 
Guss, 2001), which have been reported in both the horse pathogenic subspecies of 
S. equi. Notably the FNE protein is called FNZ in subsp. zooepidemics (Lindmark 
et al., 1996) and is cell wall-anchored, whereas it is a truncated, secreted protein 
called FNE in subsp. equi. In S. pyogenes, binding to fibronectin is important since 
it has been reported to have an impact on the internalisation of the bacteria into 
host epithelial cells (Talay et al., 1992, Molinari et al., 1997). Fibronectin is one 
component in the extracellular matrix (see section Extracellular matrix) and is an 
abundant protein in the mammalian body also present in soluble form in plasma.   14
 
Table 2. Extracellular proteins previously reported in S. equi subsp. equi and subsp. 
zooepidemicus 
 
Protein Feature Anchored
/ Secreted
Reference in  subsp. 
zooepidemicus
CNE collagen-binding anchored Lannergård  et al. 2003  CNE 
EAG  α2-macroglobulin-
albumin-, 
IgG-binding
anchored Jonsson et al. 1995 
Lindmark et al. 1999 
Flock et al. 2004 
ZAG 
FNE fibronectin-
binding
secreted Lindmark et al. 2001 
Lindmark et al. 1996 
FNZ 
FNEB fibronectin-
binding
anchored Lannergård et al. 
in press; 
Hong et al. 2005 
FNZ2 
SeM fibrinogen-
binding
 (M-protein)
anchored Timoney et al. 1985; 
Srivastava et al. 1985 
not found 
SePE-H 
(SeeH) 
exotoxin secreted Artushin et al. 2002  not found 
SePE-I 
(SeeI) 
exotoxin secreted Artushin et al. 2002  not found 
SeeL       
(SPE-Lse) 
exotoxin secreted Proft et al. 2003  SZEL 
SeeM     
(SPE-Mse) 
exotoxin secreted Proft et al. 2003  SZEM 
SFS fibronectin-
binding
secreted Lindmark et al . 1999  SFS 
SzPSe fibrinogen-
binding
 (M-like protein)
secreted Timoney et al. 1997  SzP 
 
S. equi also expresses a collagen-binding protein, CNE (Lannergard, Frykberg 
& Guss, 2003) that is similar to the previously reported virulence factor CNA in 
Staphylococcus aureus. A multi-binding protein called EAG/ZAG (Jonsson, 
Lindmark & Guss, 1995, Lindmark, Nilsson & Guss, 2001) is also present in both 
subspecies. EAG is a multi-binding protein with an N-terminal α2-macroglobulin-
binding domain, followed by an serum albumin-binding domain and the C-
terminal IgG-binding domain. 
 
Toxins 
S. equi subsp. equi expresses four superantigens called SePE-H, SePE-I (Artiushin 
et al., 2002), SeeL and SeeM (Proft et al., 2003) (Table 2). These proteins are 
homologous to the pyrogenic exotoxins previously reported in the more 
investigated species S. pyogenes (Smoot et al., 2002). These toxins have an 
immuno-modulating capacity and bind to variants of class II MHC molecules and 
to the beta-chain in the T-cells, resulting in a T-cell proliferation, which leads to   15
an enhancement of susceptibility to endotoxic shock. SeeL and SeeM have 
homologues in subsp.  zooepidemicus (Proft et al., 2003, Alber et al., 2005) 
whereas this does not seem to be the case with SePE-H and SePE-I. There have 
been reports of differences in expression of toxins between the two subspecies 
when comparing culture supernatants of various isolates from S. equi. The 
subsp. zooepidemicus does not express the SePE-H and SePE-I exotoxins, whereas 
subsp. equi does, indicating they could be important in explanation of the 
difference in virulence between the two subspecies (Artiushin et al., 2002). 
 
Vaccination against S. equi infection 
There are three vaccines against strangles available today. None of these gives full 
protection from the disease and both the degree of protection and the safety of the 
animals immunised differ between all three. 
 
Pinnacle
TM I.N. (Pinnacle
TM) was introduced in the US in the late 1990s. It is a 
vaccine consisting of a live attenuated strain of subsp. equi lacking the hyaluron 
capsule. The vaccine is distributed intranasally to the horse as a spray, thus giving 
local nasopharyngeal antibodies believed to be important in protection. However, 
since a horse immunised with the Pinnacle strain has been exposed to a strain of 
bacteria without any genetic markers, it cannot be distinguished from a horse that 
has simply been infected and has strangles (Walker & Timoney, 2002). Since the 
Pinnacle bacteria can sometimes revert to their original state, produce a capsule 
and become aggressive, this is a concern because the vaccine can then cause the 
disease instead of protecting from it. 
 
Strepguard (STREPGUARD
TM) is another vaccine, consisting of an adjuvanted 
extract from treated bacterial cells mainly consisting of M-protein. This vaccine is 
injected intramuscularly. It has been found that the M-proteins elicit antibodies 
that give weak, if any, protection (Meehan, Nowlan & Owen, 1998). Furthermore, 
the animal tends to suffer from a small infection and inflammation at the site of 
injection. This in combination with the fact that the vaccine does not result in 
local, nasopharyngeal antibodies gives a vaccine more likely to reduce the severity 
of the disease rather than one that gives complete protection. 
 
Recently a new vaccine has been introduced, Equilis StrepE (Equilis), which 
consists of a live attenuated strain of subsp.  equi, different from the Pinnacle 
strain. The vaccine is injected into the lip of the horse and the injection is likely to 
cause a swelling and inflammation at the injection site (Newton, Waller & King, 
2005). Some horses express clinical signs of strangles after the vaccination, and, 
furthermore, this vaccine is not effective for more than three months, which also is 
a problem for a fully protective vaccination. 
 
In conclusion, none of the three vaccines currently available on the market is as 
effective as required for an efficient large-scale vaccination of horses. This makes 
the need for a more effective vaccine high and desirable.   16
Extracellular matrix 
The extracellular matrix (ECM) is a complex structural assembly surrounding and 
supporting cells within mammalian tissues. Often the ECM is referred to as the 
connective tissue and can be said to be composed of three major classes of bio 
molecules. These are:  
Structural proteins ( i.e. collagen and elastin) involved in maintaining the 
structure of connective tissue and the rigidity of cell structure 
Specialised proteins acting as link proteins in adhesion and cell-cell interactions 
(e.g. fibronectin, and laminin) 
Proteoglycans acting as space filling molecules which function as shock 
absorbing material in the tissue. 
 
Mammalian collagen 
The word collagen comes from the Greek kólla meaning glue and géneo meaning 
produced/created and explains rather nicely what most collagens do. Collagen is 
the most abundant protein in the mammalian body and the collagens constitute a 
family of extra-cellular proteins, which have a structural role as their primary 
function (Ricard-Blum & Ruggiero, 2005). The structure consists of a glycine 
backbone which forms an alpha helix. Glycine (G) is the first amino acid in a 
repetitive triplet, called Gly-Xaa-Yaa or GXY, which is the core of the protein. 
Usually the amino acids in the second (X) and third (Y) positions are proline (P) 
and hydroxyproline (O) (Fig. 1). 
 
 
Figure 1. Schematic diagram of mammalian collagen. 
 
The collagen protein is assembled in the endoplasmatic reticulum (ER) and the 
Golgi apparatus and the proline is hydroxylated after passing through the 
membrane, thus making the collagen stable. The stability has been proven to be 
linked to the formation of triple helices, with three alpha-chains linked together as 
a superhelix (right-handed). The collagen triple helix is one of the most stable 
structures found in nature. Collagen is divided into several subgroups depending 
on the secondary structure and most collagens are able to form supramolecular 
aggregates. This also means the each collagen member of a certain subclass shares 
a common chain structure. The first part of the superfamily to be discovered, and 
therefore also called classical collagens, were the collagens that are responsible for 
the formation of fibrils. The fibrils are relatively simple in structure, a large triple 
helix formation flanked by two globular extensions, and are made up of minor and 
major fibrillar collagens in mixtures; in connective tissue collagen types I, III and   17
V and in cartilage collagen types II and XI (Fichard, Kleman & Ruggiero, 1995). 
Collagen XXIII may contribute to cell adhesion via its RGD site and KGD motifs 
(Nykvist et al., 2001, Banyard, Bao & Zetter, 2003), whereas collagens XV and 
XVIII are major components in the epithelial and endothelial basement membrane 
zones in a variety of tissues (Myers et al., 1996, Ortega & Werb, 2002).  
 
Fibronectin 
The role of fibronectin is to attach cells to several various types of extracellular 
matrices, thus working as an adhesion molecule. This is reflected in the Latin 
origin of the name, fibra meaning fibre and necto meaning to attach or put 
together. Fibronectins are dimers of two similar peptides, each with at least six 
tightly folded domains with different affinity for various substrates, i.e. heparin, 
fibrin, collagen, cell surface receptors. The latter binding domain contains a 
consensus amino acid sequence, RGD, which is of importance when connecting to 
cellular integrins in signalling and other response mechanisms. This domain is also 
present in vitronectin, another major adhesion protein in the ECM which promotes 
cell attachment, proliferation and spreading (Schwarz-Linek, Höök & Potts, 2004) 
and RGD can also be found in bacterial proteins (Isberg & Tran Van Nhieu, 1995, 
Nilsson et al., 2004). Fibronectin that is bound to a streptococcal cell can act as a 
bridging molecule towards the host cell integrins that initialise the uptake process 
leading to internalisation of the bacterial cells, which has been shown to occur in 
Group A streptococci (GAS) (Kreikemeyer, Klenk & Podbielski, 2004). 
 
Proteoglycans 
Proteoglycans are large carbohydrates that consist of repeating disaccharide units 
called glycosaminoglycans (GAGs) with a protein core forming complex high 
molecular weight components of the ECM. These function as stabilisers and water 
absorbance material when water from certain tissues leaks into the extracellular 
matrix. The GAGs differ in their physiological significance and even though their 
dominant component is disaccharide, a heterogeneity exists in the sugars when 
composing the different classes of GAG. For example, hyaluron (former called 
hyaluronic acid) is unique among the GAGs since it does not contain any sulphate 
and is not covalently attached to the proteins like the other proteoglycans. 
However, it forms non-covalently formed complexes with proteoglycans in the 
ECM and can displace large volumes of water in the tissue. 
 
Collagen-like proteins in bacteria 
Since the stability of mammalian collagen is based on hydroxylation of the proline 
into hydroxyproline and since bacteria lack the ability to form this amino acid, it 
was not believed that bacteria could form stable collagen-like structures. However, 
early in the 21
st century, three different research groups showed that the bacterium 
S. pyogenes expressed collagen-like proteins called Scl1/sclA (Lukomski et al., 
2000, Rasmussen, Eden & Bjorck, 2000, Xu et al., 2002) and Scl2/SclB 
(streptococcal collagen-like proteins A/1 and B/2) (Lukomski et al., 2001, 
Rasmussen & Bjorck, 2001, Whatmore, 2001). It was established that the proteins 
were stable in structure and expressed during early log phase in cultures grown in   18
vitro. Furthermore, the stability of the protein was found to be due to a number of 
repeats present in the collagen-like domain where the important triplet G-P-O 
(Gly-Pro-Hyp) in mammalian collagen is replaced by the triplets KGD (Lys–Gly-
Asp) and KGE (Lys–Gly-Glu). These triplets contribute to stability in the same 
way as the imino acids proline (P) and hydroxyproline (O) (Berisio R et al., 2004). 
It has recently also been reported that some of these collagen-like proteins can 
bind to certain integrin motifs in mammalian cells, thus being involved in the 
bacterial-host cell interaction (Humtsoe et al., 2005). 
 
Integrins 
The integrins are part of a family of adhesion receptors on the cell surface that are 
involved in cell-cell, cell-ECM and cell-bacterial interactions. The receptors are 
described as transmembrane glycoproteins consisting of two non-covalently linked 
subunits acting as a heterodimer. The subunits, one α- and one β-subunit can be 
combined in several different combinations, giving a large variety of integrins. To 
date, 18 α-chains and 8 β-chains together combined into 24 different heterodimers 
have been found in mammals (Fig. 2) (Hynes, 2000). 
 
 
Figure 2. The integrin receptor family. The different α- and β- heterodimer combinations 
with indicated subfamilies and ligand-binding. The grey circles(α1, α2, α11, α10,) are 
collagen-binding integrins together with β1 and have I-domains. RGD-receptors are found 
inside the triangle and the leukocyte-specific receptors inside the striped box. Entities α3, 
α6, α7 and α4 are laminin-binding receptors as are α1β1 and  α2β1. All the β2 integrins 
(striped box) have I-domains. (Modified from Hynes, 2000) 
 
Both subunits are involved in binding the ligand and the integrin structure forms 
a globular head in the N-terminal end and a long stalk region that is connected to 
the smaller intracellular C-terminal cytoplasmic bound tail. The ligand-binding 
region is determined to the N-terminal region of the heterodimer (Fig. 3). 
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The α subunits form a so-called sevenfold β-propeller where seven homologous 
repeats bind together in the N-terminal end, similarly to previously reported 
nucleotide binding pockets (Springer, 1997) (see Fig. 3). There are also other 
previously reported binding sites, e.g. binding motifs for various cations, and for 
four of the α-subunits a von Willebrand factor A-domain (I) is found in the 
propeller region. This domain is involved in direct recognition and binding of the 
ligand in question(Kern & Marcantonio, 1998). The propeller heads of the α-
subunit show homologies to each other between the α-subunits. 
 
Figure 3. Schematic figure of the 
integrin structure with an I-domain 
present. The α-subunit form an β- 
propeller in the N-terminal where 
the I-domain will be located if an I-
domain is present. The α- and β-
chains are non-covalently linked 
and transmembrane. 
 
 
 
 
 
 
 
 
 
The β-subunit has a cysteine-rich N-terminal end involved in the association 
with the α-subunit and is dependent on the propeller shape in order to get correct 
folding. The cytoplasmic tails of the β-subunits have similarities in that 6 of the 8 
subunits described have a high degree of similarity in that region.  
 
The integrins as heterodimers can be divided into several subgroups, e.g. the 
collagen-receptor subgroup where the α1β1,  α2β1,  α10β1 and α11β1. Of this 
subgroup, α1β1, α2β1 and α11β1have been shown to recognise the GFOGER-motif, 
and other GFOGER-like motifs, found in certain collagens (Zhang et al., 2003). 
The collagen-binding of these four integrins is not due to RGD-motif recognition,. 
This in contrast to the fibronectin-binding integrins α5β1 and αVβ3 where the αv 
integrins bind to the RGD-motif found in fibronectin (Nykvist et al., 2001) and 
this motif is also present in several bacterial proteins (Isberg & Tran Van Nhieu, 
1995, Nilsson et al., 2004). αV integrins could play essential roles in cell growth, 
survival and migration (Sheppard, 2004), since knock out mice have certain 
mutations with 100% mortality even though other tissues and organs develop as 
normal. αV-integrins combine with five different β-subunits (β1, β3, β5, β6, β8) 
(Fig. 2). The αVβ3 form a heterodimer with a structure similar to a ‘stopping 
figure’ bending down when inactive, and most likely this is true for all αV-
integrins. This structure is inactive in contracted form, due to steric inhibition of 
binding to the binding site, and when activated the head ‘opens up’ and makes 
ligand-binding possible. αVβ3 are activated when inflammation occurs and they act 
as a signal receptor in order to activate the immune response (Wilder, 2002).   20
“One never notices what has been done, one 
only can only see what remains to be done” 
Marie Curie 
 
Present study 
Aim 
When this study was initiated the genome of subsp. equi had not been annotated 
but was available only as shorter contigs without annotation, and information 
about extracellular proteins in this subspecies was scarce. Therefore, to identify 
extracellular proteins in S. equi subsp. equi, a signal sequence phage display was 
used. A novel collagen-like protein called SclC was found and characterised. 
Using bioinformatics, this protein was defined as a member of a novel family of 
collagen-like proteins in subspecies equi. One of the aims was to investigate the 
collagen-like protein SclC as a vaccine component against strangles in a mouse 
model and finally study its biological role in host cell-bacterial interactions in a 
collagen lattice contraction system. 
 
Phage display 
Identification of potential virulence factors 
In order to identify potential virulence factors, 
molecules involved in adhesion and infection 
have to be identified and analysed. The processes 
of investigating such factors include gene cloning 
and different strategies to express the genes in 
another host, usually E. coli. Phage display is a 
technique developed for expressing proteins in 
fusion with the phages’ own coat proteins (Smith, 
1985). The filamentous phage M13 has a capsid 
consisting of approximately 2700 copies of the 
major coat protein pVIII and much lower 
numbers of proteins pIII, pVI, pVII and pIX 
(Fig.  4). The phages infect E. coli and their 
progeny are secreted without killing the bacteria. 
When foreign DNA is inserted into one of the 
genes encoding a coat protein, fusion proteins are 
then expressed on the surface of the phage. The 
phage display technique was improved by 
Bass et al. (Bass, Greene & Wells, 1990) who 
instead of a phage used phagemid-vectors. 
 
Figure 4. A schematic diagram 
of a phage with its coat proteins 
   21
A phagemid used for phage display is a plasmid with a phage origin of 
replication, the sequences required for packaging into the phage particle and a 
phage gene encoding a specific phage coat protein, usually pIII or pVIII. When 
foreign DNA with an open reading frame (ORF) is inserted into the phagemid, 
only one or a few fusion proteins are displayed on the surface of the phagemid 
particle. This technique requires a helper phage that allows all other phage 
proteins to co-infect the E. coli cells containing the phagemid in order for all other 
phage proteins to be expressed. This is more useful since the copy number of the 
expressed fusion protein decreases, thus allowing studies of weak and strong 
binding phages. The use of a pVIII phagemid-vector results in expression of a 
varying number of copies of the protein in question, compared to the pIII system 
where on average less than one fusion protein per phage is obtained. 
 
In order to study interactions between bacterial proteins and ligands, shotgun 
phage display can be used (Jacobsson et al., 2003). In shotgun phage display, the 
library is constructed from bacterial chromosomal DNA that is fragmented 
randomly and then the fragments are inserted into a phagemid vector. 
Theoretically this would mean that a large enough library would contain phagemid 
particles expressing all genes, in the genome of the organism, as polypeptides on 
the surface. 
 
Signal sequence phage display 
Signal sequence phage display is an application using a modified phagemid 
vector, pG3DSS that lacks the signal sequence required for transport of the fusion 
protein to the bacterial membrane, where incorporation into the phage particle 
occurs (Rosander et al., 2002). Thus, only phages containing a vector with an 
insert encoding a signal sequence display a fusion protein on the phage surface. 
The vector also encodes an E-tag, a short peptide recognised by an antibody. By 
selecting the library against anti-E-tag antibodies, phages expressing a fusion 
protein can be isolated. Theoretically this technique allows for selection of ‘all’ 
signal sequence containing proteins encoded by a genome, secreted as well as cell 
membrane-anchored proteins, including adhesins, enzymes and transport proteins. 
The technique has previously been used in investigations of extracellular proteins 
in  Staphylococcus aureus (Rosander et al., 2002), Bradyrhizobium japonicum 
(Rosander et al., 2003) and Lactobacillus reuteri (Wall et al., 2003). 
 
Panning of the signal sequence library (I) 
A signal sequence phage library was made from genomic DNA from subsp. equi 
strain 1866, which was fragmented by sonication and then ligated into the 
pG3DSS vector lacking a signal sequence. Primarily the library was panned 
against anti-E-tag antibodies in order to identify fusion proteins with the E-tag 
peptide and then inserts of the clones were sequenced and investigated. The 
panning was done in microwells for two consecutive cycles to enrich the E-tag 
expressing clones (Fig. 5).   22
 
Figure 5. Construction and panning of the signal sequence phage display library. The DNA 
is fragmented and inserted into the vector pG3DSS. Fragments with an open reading frame 
are expressed in fusion with the E-tag peptide and the partial gene III protein. Panning of 
the library is done in microwells coated with anti E-tag antibodies. E. coli cells are infected 
with the eluted phagemid particles for DNA isolation, and sequencing of the foreign DNA. 
 
Sequencing 120 clones from the first and second pannings revealed 20 new 
signal sequences found in 48 unique clones. The ORFs investigated showed 
homologies to previously described putative proteins in S. pyogenes, S. agalactiae 
and S. dysgalactiae (Table 1 in I). Notably there was a high frequency of ABC 
transporters among the identified putative proteins, as well as a number of 
homologues to predicted conserved hypothetical proteins. 
 
The library was also panned against α2-M as well as against horse serum. Of the 
clones investigated, no novel proteins with affinity for either of the ligands could 
be detected. This is most likely due to the size of the DNA fragments used for 
construction of the library (~0.3 - 3 kb with the majority of the fragments shorter 
than 1 kb). In order to be expressed and to bind to the ligand, the clones have to 
encode both the signal sequences and the binding regions, which would require 
fragments larger than this. Panning of a pVIII shotgun phage display library from 
subsp. equi against other ligands has resulted in findings of proteins interactive 
with ligands (Lindmark & Guss, 1999), supporting the previous statement.   23
SclC (I) 
Characterisation of the collagen-like protein 
One of the clones isolated from the pannings of the signal sequence phage display 
library harboured an ORF encoding the N-terminal part of a collagen-like protein 
called SclC. The protein had similarities to the previously described SclB in 
S. pyogenes (Whatmore, 2001). The complete SclC protein is approximately 30 
kDa in size and consists of an N-terminal signal sequence followed by an A-region 
with no known homologies, a collagen-like (CL) region followed by a proline-rich 
wall-associated (W) region ending with an LPXTG-motif that proceeds the C-
terminal membrane anchoring domain (M) (Fig. 6). This, combined with the fact 
that in S. pyogenes the collagen-like proteins have been reported to display a high 
degree of polymorphism in several of the serotypes investigated, made the protein 
in subsp. equi interesting to study further. 
 
The collagen-like region (CL) is similar to the previously reported collagen-like 
proteins from bacteria (Lukomski et al., 2000, Rasmussen, Eden & Bjorck, 2000, 
Lukomski et al., 2001, Rasmussen & Bjorck, 2001, Whatmore, 2001, Xu et al., 
2002) in the aspect of G-X-Y repeats and ending in a proline-rich wall spanning 
part. The G-X-Y repeats are not identical in the species S. pyogenes and 
subsp. equi but the similarity of the organisation of the proteins indicates that they 
are related. SclC was found to have most similarities to the SclB protein of 
S. pyogenes. The proteins do not have exactly the same amino acid sequence yet a 
similarity can be observed. The total content of KGD/KGE repeats in the collagen-
like region is also consistent between the proteins (Fig. 2 in I), indicating 
similarity. Comparing the various collagen-like proteins found in S. pyogenes, the 
same observation can be drawn. The different collagen-like proteins vary 
depending on which serotype and which M-protein is expressed in the strain. SclC 
also differ from previously described collagen-like proteins since there are no 
repetitive regions within the CL-region of the protein, which has been found in the 
collagen-like proteins found in S. pyogenes (Lukomski et al., 2001, Rasmussen & 
Bjorck, 2001, Whatmore, 2001, Xu et al., 2002). Furthermore, SclC lacks the 
linker region PKSAPS found in Scl1 in S. pyogenes (Lukomski et al., 2000). 
 
Protein production and binding studies 
To study whether the SclC protein displays binding to components in plasma or 
the extracellular matrix, different binding experiments were performed. P24, the 
full-length mature protein, was expressed in E. coli using the IMPACT
TM system 
from New England Biolabs. This system uses a vector that produces a three-part 
fusion protein with a protein splicing element called intein, which when DTT is 
added uses self cleavage to produce an end product of a purified recombinant 
protein. Binding investigations were performed in microwells with different 
immobilised proteins (fibronectin, fibrinogen, hyaluronan, collagen I and CNE) as 
well as horse sera and plasma using 
125I-labelled P24. The ligands were coated in 
microwells to which the 
125I-labelled P24 was added. No binding could be 
detected to any of the ligands tested. 
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To further study whether SclC displays binding to component(s) that occur in 
low concentrations in horse plasma, the P24 protein was immobilised on an NHS-
activated HiTrap column (Amersham Biosciences). Plasma was passed over the 
column and after washing the bound material was eluted by lowering the pH. The 
eluted samples were subjected to native PAGE and Western blotting. The result 
showed that one of the fractions contained protein fragments, which in Western 
blot reacted with 
125I-labelled P24. This fraction was then separated on a 2D-
polyacrylamide gel and the spots obtained were sequenced and analysed (data not 
shown). However, they turned out to be the heavy and light chains of IgG and IgM 
molecules. This was not surprising considering the large amount of plasma passed 
over the column, since plasma from horses, both those previously infected with 
subsp. equi and horses with no history of infection, contain detectable levels of 
antibodies against the protein (see Fig. 3 and Fig. 4 in I). Thus, passing plasma 
over immobilised P24 would result in purification of these antibodies. In addition, 
subsp. zooepidemicus is likely to express SclC. This subspecies is part of the 
normal flora in horses and accordingly, the immune system has probably 
developed antibodies against the protein. However, the antibody titres against 
SclC are significantly higher in horses previously infected with subsp. equi, 
supporting the theory that even though the protein might be expressed in 
subsp. zooepidemicus, infected horses are exposed to the protein to a much higher 
degree (I). 
 
 
Figure 6. The collagen-like proteins found in S. equi subsp. equi. Ss; signal sequence, A; 
the variable region, CL; the collagen-like region, W; proline rich wall spanning region, M; 
membrane spanning region, and the LPXTG-motif in between the two most C-terminal 
regions. 
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SclD-SclI (II) 
The family of collagen-like proteins 
When further analysing the genome database found at Sanger.co.uk, six novel 
open reading frames similar to the SclC were discovered. The novel sequences 
showed homologies in both the nucleotide sequences and in the deduced amino 
acid sequences. The six deduced amino acid sequences showed similarities in 
organisation with an N-terminal signal sequence, a variable region (A) followed 
by a collagen-like region (CL) expressing Gly-X-Y repeats and a proline-rich 
region ending with an cell wall-anchoring LPXTG motif which precedes the C-
terminal membrane-anchored domain (Fig. 6). Although the proteins varied in 
size, the total content of glycine varied between 17.2% and 22.6 % (Table 3). 
 
Table 3. Amino acid content in the collagen-like proteins SclC – SclI. Mean values and 
standard deviation are shown as percentages and in percentage units. The proteins with the 
highest and lowest content are shown in the right-hand column. 
 
Amino 
acid 
Mean 
value 
        SD ±           Least        Most 
A (Ala)  8.4%  0.028  SclG SclC
R (Arg)  5.1%  0.025  SclD SclG
D (Asp)  4.0%  0.017  SclG SclC
Q (Gln)  8.8%  0.027  SclC SclH
E (Glu)  9.7%  0.026  SclH SclG
G (Gly)  19.8%  0.020  SclC SclI
K (Lys)  11%  0.020  SclH SclD
P (Pro)  10%  0.031  SclD SclH
 
A phylogenetic tree of the nucleotide sequences shows that the three shortest 
sequences cluster closest together (Fig 1. in II). Four of the proteins (SclD, SclE, 
SclG and SclI) also contain a repetitive sequence GEKGD/EQGQR/K, whereas 
the remaining three do not. Comparisons between the KGD/KGE triplets that have 
been reported to stabilise the collagen-like proteins found in bacteria show that the 
collagen-like proteins found in subsp. equi contain more of these triplets than the 
proteins from S. pyogenes and collagen I (Table 4). This is true for all proteins 
except SclH, which clusters furthest away from the other proteins in subsp. equi 
(Fig. 1 in II). The SclD protein with the highest amount of KGD/E triplets has the 
lowest amount of proline, supporting the previous analysis of differences in 
mammalian collagen and prokaryote collagen-like structures (Persikov, Ramshaw 
& Brodsky, 2005). 
 
In S. pyogenes, two types of collagen-like proteins, Scl1/A and Scl2/B, have 
been reported and investigated (Lukomski et al., 2000, Rasmussen & Bjorck, 
2001, Whatmore, 2001, Akesson et al., 2004). The various serotypes of S.  
pyogenes express different subtypes of M-like proteins and also different subtypes 
of the two collagen-like proteins (Rasmussen, Jacobsson & Bjorck, 2003). Since 
these proteins are found to vary, it has been concluded that there is a serotype 
variation in the collagen-like proteins, since there are only two proteins present in 
each strain/serotype. In contrast, subsp. equi seems to have seven collagen-like   26
proteins since all of these are found in both strain 1866 and in the different strain 
sequenced and presented at Sanger.co.uk . 
 
Table 4. Content of imino acids and KGD/E triplets in the collagen-like region of the 
proteins. Proline is found in the second and/or third positions of the GXY-triplets in the CL-
region 
 
  Imino acids  KGE + KGD 
Protein  Total #  % of X + Y  Total #  % of triplets 
SclC  16  22  6 + 7  35 
SclD  7  7.8  11 + 7  40 
SclE  10  10  13 + 1  28 
SclF  30  22  7 + 12  28 
SclG  16  11  16 + 2  25 
SclH  39  30  0 + 10  15 
SclI  30  15  14 + 11  25 
Scl1*  15  15  6 + 4  20 
col1A1**  236  35  6 + 6  3.6 
*Streptococcal protein Scl1 (Persikov et al., 2005) 
**Mammalian collagen type 1 (Persikov et al., 2005) 
 
The Scl proteins Scl1/A and Scl2/B in S. pyogenes have previously been 
reported to be able to form a collagen-like triple-helical structure (Rasmussen, 
Eden & Bjorck, 2000, Xu et al., 2002). Using electron microscopy, the authors 
demonstrated that the Scl proteins are organised into ‘lollipop’-structures similar 
to those seen in human proteins containing collagenous domains. Whether the Scl 
proteins in subsp.  equi can also form this type of structure remains to be 
determined but analysis of putative protein structure (including tests such as 
Hopp/Woods hydrophobicity and von Heijne transmembrane) using the software 
Macvector 8.02 (Accelrys, Madison, WI) indicates that it is likely that SclC - SclI 
can also form this type of structure.  
 
Antibodies against SclC recognise SclD - SclI 
The six novel collagen-like proteins SclD- SclI were expressed, both as mature 
proteins and as only the A-regions, to investigate whether they are recognised by 
antibodies against SclC. Microwells were coated with the mature proteins and the 
A-regions, respectively and the binding of antibodies against SclC was tested 
using ELISA. Only the mature proteins containing the CL regions were recognised 
by the antibodies (Fig. 2 in II). This indicates that the previous results in the 
investigation of horse sera and recognition of SclC (I) could be the result of 
recognition of antibodies against all the collagen-like proteins in subsp. equi rather 
than the SclC protein alone. Thus all CL-regions are recognised by purified 
antibodies against SclC and the antibodies used are not only directed to the unique 
A-region of SclC.  
 
In order to establish whether horses previously infected with subsp. equi had 
antibodies recognising all collagen-like proteins, an ELISA with only the A-
regions from each protein was performed. This was intended to avoid detection of   27
antibody binding to the similar CL-region in all seven proteins. The results 
showed that all sera from horses previously infected by subsp.  equi contained 
antibodies against all seven A-regions, but in varying amounts. The results 
indicate that the proteins are expressed during subsp.  equi infection. This was 
further confirmed when horse sera from both infected and uninfected horses was 
investigated against the A-region from SclC, where there was a significantly 
higher antibody titre in horses previously infected with subsp. equi (Fig. 4 in III). 
The cross-reaction between the antibodies against SclC and the other six proteins, 
SclD – SclI, cannot account for all the results in the previous investigation of 
horse sera against SclC (in I) since the results from the ELISA investigation of 
each A-region had a variation in amounts of antibodies within each serum. 
However, to measure antibody response against an individual Scl protein it has 
become obvious that antibodies that only react with the respective A-regions are 
needed. 
 
The antibodies that recognise the CL-region in SclC in I  are most likely a 
mixture of antibodies that can react with all seven collagen-like proteins. This 
raises the question whether an immunisation with SclC gives antibodies directed 
against the collagen-like region, which could then react with horse collagen. 
Immunisation of rabbits with SclC gave antibodies recognising the A-regions, CL-
regions and mature protein (II), showing that antibodies are directed to different 
regions of the protein and indicating that this might not be a main concern. 
However, unspecific recognition of horse collagen by the antibodies needs to be 
further investigated for certainty. 
 
Expression under different conditions 
To investigate whether the collagen-like proteins are expressed in vitro, 
subspecies equi strain 1866 was grown in Todd Hewitt Broth supplemented with 
0.6 % yeast extract (THB) combined with additional supplement of 10 % horse 
sera under aerobic, anaerobic and microaerobic (10 % CO2) conditions. After 
harvest, the intact bacterial cells were dot blotted onto nitrocellulose (NC)-filters. 
The supernatant from lysed cells, separated through centrifugation, was run on a 
SDS-PAGE gel and then blotted onto NC filters. All the NC-filters were treated 
with human IgG in order to block binding to the EAG protein, which binds the Fc-
part of antibodies. Affinity purified anti  SclC rabbit antibodies were incubated 
with the pre-blocked filters. It was found that the bacterial cells grown under 
microaerobic and anaerobic conditions showed positive reactions, indicating that 
the collagen-like proteins were expressed under these conditions (data not shown). 
Similar results were obtained when the lysates from the anaerobic and 
microaerobic conditions were tested. In the addition, when the 10 % horse sera 
was added to the THB medium, the antibody binding was found to be stronger. 
These unpublished data are preliminary, and in the future it is suggested that 
another method like Real Time PCR should be used to study the expression of the 
scl-genes. Real Time PCR using primers specific for the specific proteins would 
probably give a more clear result. Still, the preliminary results suggest that the 
proteins could be expressed during less aerobic conditions.   28
Using SclC in a vaccination study in a strangles model in mice 
(III)  
Immunity and vaccines 
It has previously been shown that horses that have suffered from strangles and 
then recovered are protected from a re-infection with subsp. equi for at least three 
months (Sweeney et al., 2005). This indicates that formation of protective 
antibodies has occurred and that it should therefore be possible to vaccinate 
against the disease if the right components are used as antigens. It has also been 
debated whether intranasal vaccination would result in IgA antibodies rather than 
the IgG antibodies that are more often produced during subcutaneous vaccination. 
When infection occurs in the mucosal layer in the nose of the horse, it is likely that 
IgA antibodies provide better protection than the IgG antibodies usually occurring 
in the bloodstream. Meehan et al. (Meehan, Nowlan & Owen, 1998) showed that 
M-like protein complexes gave protection in mice against lethal challenge with 
subsp.  equi. However, when the M-protein was used as an antigen against a 
challenge with subsp.  equi in horses, the protection was small and not useful 
(Sheoran, Artiushin & Timoney, 2002). 
 
Adjuvants are important in order to enhance the immune response, i.e. production 
of antibodies, to a particular antigen. Therefore the antigen is mixed with an 
adjuvant when introduced to the immune system, i.e. by vaccination. It is 
important that the adjuvant in itself is not toxic. Different adjuvants can be used to 
stimulate production of different antibody classes. The most powerful mucosal 
adjuvants today are cholera toxin (CT) and Escherichia coli heat-labile 
enterotoxin (Rappuoli et al., 1999). These toxins occur naturally in the diseases 
cholera and traveller’s diarrhoea, respectively. However, they are high in toxicity 
and not suitable in their native form for vaccination studies and vaccine 
development. A less toxic adjuvant that still elicits a good antibody response is the 
non-toxic recombinant B-subunit of the E. coli enterotoxin (EtxB), which is 
immunogenic by both parental and mucosal routes and elicits a strong antibody 
response when administered mucosally (Millar, Hirst & Snider, 2001). 
 
Another type of adjuvant is the ISCOM (immune stimulating complex), which is 
a particle with a cage-like structure, typically 40-100 nm in diameter, comprised of 
cholesterol, phospholipid and Quillaia saponin (Morein et al., 1987). The ISCOM-
matrix is formed when the antigen is mixed with the ISCOM, sometimes leaving 
the antigen inside the ISCOM-particle. When the ISCOM is administrated 
mucosally a strong IgA response is induced, both locally and in remote mucosal 
areas (Morein, Hu & Abusugra, 2004). Several ISCOM-based vaccines are under 
development and one vaccine against equine influenza (EQUIP F) is currently on 
the market (Crouch et al., 2005). 
 
Immunisations and challenge procedure in a mouse model 
A mouse model has previously been used in testing whether other recombinant 
proteins (SFS, EAG and FNZ of S. equi) could be used as antigens in a vaccine 
against subsp. equi infections (Flock et al., 2004). Combinations of these proteins 
were also used in horses to investigate whether they could give antibodies   29
recognising these antigens. The results showed that vaccination in mice had a 
protective effect and that horses responded to the introduced antigens. It was 
therefore thought to be interesting to investigate whether vaccination in the mouse 
model using SclC also resulted in a protective effect. 
 
The mice were immunised intranasally (i.n.) with SclC, followed by booster 
vaccinations on days 7, 14 and 21. The challenge, when bacteria of subsp. equi 
were introduced into the nose of the animals, took place 28 days after the first 
vaccination. The animals were then monitored for weight change and growth of 
subsp. equi in the nose in order to determine the level of protection. 
 
The mice immunised were found to have significantly less weight change than 
the non-immunised animals (Fig. 7), as well as having less colonisation of bacteria 
in the nose tract (Fig. 6 in III). In addition, the antibody levels were inversely 
correlated to the weight change (r-values = 0.62) i.e. the weight loss was less in 
animals with higher antibody levels, indicating that it was the antibodies against 
SclC that were responsible for the protection. 
 
 
Figure 7. Weight change (%) in mice immunized with SclC. Mice (n=15) (open squares) 
were immunized with SclC and control mice (n=15) (closed squares) with adjuvant only, 
followed by infection with subsp. equi. Mean values of weight change ± SE are shown. 
 
In another experiment mice were vaccinated with CNE and EAG, one at the 
time and and in combination. The results of these immunisations turned out to be 
positive in aspect of degree of protection. The combination of CNE and EAG was 
more efficient than CNE alone. Interestingly, vaccination with both the collagen-
binding protein CNE and the collagen-like protein SclC gave protection. However, 
the fibronectin-binding protein FNEB that also was tested as an antigen did not 
result in any protection. The conclusion from these experiments was that when 
continuing with the immunisation studies in horses, a vaccine that combines the 
proteins SclC, CNE and EAG would be interesting for further studies. 
 
-20
-15
-10
-5
0
5
01234567
-20
-15
-10
-5
0
5
01234567
Days after challenge
W
e
i
g
h
t
 
c
h
a
n
g
e
 
(
%
)  30
The effect of recombinant protein from S. equi on collagen 
lattice contraction (IV) 
Studies of the recombinant protein FNZN 
Mesenchymal cells, e.g. fibroblasts or smooth muscle cells, that are cultured in a 
three-dimensional collagen lattice contract the lattice typically within 24 hours and 
this process  is referred  to as cell-mediated collagen gel contraction. Cells from 
the murine myoblast cell line C2C12 mediate collagen lattice contraction after 
stimulation with platelet-derived growth factor (PDGF). These cells lack 
expression of collagen-binding β1 integrins (e.g. α1β1, α2β1, α10β1 and α11β1) and 
use the αVβ3 integrin for collagen gel contraction (Lidén et al. Manuscript in 
preparation). Several different extracellular proteins from S. equi were tested as to 
their ability to modulate collagen gel contraction mediated by C2C12 cells and by 
a cell line, (C2C12-α2) in which the collagen-binding β1 integrin α2β1 has been 
reintroduced by transfecting the cells Since the C2C12 does not express collagen-
binding β1 integrins, contraction of these cells could be due to activation of the 
αVβ3 integrin and the investigation of this can further studied when by adding a 
specific inhibitor of αVβ3. 
 
The recombinant proteins tested were the fibronectin-binding proteins FNZ, SFS 
and FNEB, the collagen-binding protein CNE and collagen-like protein SclC (Fig. 
1 in IV). FNZ is called FNZN in this study since only the N-terminal part of the 
protein is present in the recombinant protein, thus lacks the C-terminal fibronectin-
binding repeats. The only protein that had an effect on contraction was the protein 
FNZN. None of the other recombinant proteins had any clear effect on collagen 
gel contraction mediated by the two different cell lines. In the cell line C2C12, 
FNZN was found to enhance the contraction, which would not take place unless 
PDFG is added. In the transfected cell line C2C12-α2, where the cells contract by 
themselves, this effect could not be observed. Furthermore, the activation of the 
contraction could be blocked by adding specific αVβ3 inhibitor, indicating that 
FNZN somehow works by stimulating the αVβ3 integrin, which leads to 
contraction in the gel. 
 
To investigate whether the FNZN protein could bind directly to cells, i.e. through 
binding to αVβ3, and increase the binding of cells to different ligands, an 
interaction study of the two types of cell lines with three extracellular matrix 
(ECM) ligands were performed. These ECM ligands were; fibronectin, collagen 
type I and denatured collagen type I. The ECM proteins were immobilised in 
plastic dishes, the myoblast cells pre-incubated with FNZN and then added into 
the plastic dishes. The result showed that FNZN did inhibit the adhesion of the 
C2C12 cells to denatured collagen I but not to the other ligands tested.  
 
In order to establish weather FNZN could bind directly to the cells, FNZN was 
labelled with 
125Iodine and incubated with suspended C2C12 cells to see if any 
such binding could be detected. As shown in Fig. 6 in IV FNZN binds to the cells. 
Since the myoblast cells bind denatured collagen, FNZN was further studied in 
terms of binding to fibronectin, native collagen and denatured collagen.   31
Microwells were coated with the ligands and 
125I-labelled FNZ was added. The 
results shows that FNZN binds to both fibronectin and native collagen I (Fig. 4 in 
IV). Since FNZN binds to the 40k region of the fibronectin molecule (Lannergard 
et al., 2005), a region also responsible for the binding to collagen, it would be 
interesting to further investigate whether FNZN can inhibit binding of fibronectin 
to collagen. 
 
In conclusion the effect of FNZN to the collagen lattice contraction suggest that 
the FNZN protein stimulate contraction of C2C12 cells and do this via the αVβ3 
integrin. This intergrin is involved in the reactions against infection and 
inflammation and counteracts edema formation in tissue (Lidén et al., submitted). 
Gram-negative bacteria can cause edema due to release of lipopolysaccharides 
(LPS) and their stimulation of tissue macropahges to produce interleukin-1 in the 
connective tissue structures surrounding the capillary beds (Nedrebo & Reed, 
2002, Nedrebo et al., 2004). The vascular support system breaks down and fluid 
leaks into the tissue, thus creating edema in which the tissue can actually be said to 
collapse. In that the αVβ3 integrin can counteract the effect. The recombinant 
protein FNZN from Gram-positive S. equi seems to have the opposite effect in the 
cell system used. 
 
Contraction studies of SclC 
Humotse et al. (Humtsoe et al., 2005) have reported that certain motifs of the 
bacterial collagen-like proteins are recognised by, and react with, mammalian 
collagen-binding integrins. These motifs are party described as GLOGER, but 
there also seem to be some unknown motifs that bind as well. To establish whether 
SclC has an unknown motif reacting with mammalian collagen, it was tested in the 
collagen lattice contraction with C2C12 and C2C12-α2 cells. 
 
The results indicated that there was no reaction when SclC was added, which is 
consistent with previously reported data, since this protein does not have any of 
the reported binding sites to the collagen-binding integrins. This also indicates that 
SclC does not have any of the unrecognised motifs previously reported. The 
remaining six collagen-like proteins from subsp.  equi should also be tested to 
further investigate their role in the bacterial-cell interaction. 
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Concluding remarks 
This thesis describes seven novel collagen-like proteins found in a pathogenic 
streptococcal strain and investigates the possible biological role of one of them in 
particular. When studying extracellular proteins in the obligate pathogen S. equi 
subsp. equi, signal phage display was shown to be a powerful tool in identifying 
potential proteins harbouring a signal sequence. Furthermore, by combining this 
technique with bioinformatic tools, a novel family of cell surface-anchored 
proteins was identified. This family of collagen-like proteins consists of seven 
proteins, all sharing the same features. These proteins differ from collagen 
structures found in mammals since they do not contain hydroxyproline. The 
possibility that these proteins can form stable triple helices has not been tested. 
Although, earlier reports on similar proteins in S. pyogenes have shown that these 
proteins can form triple helices, which indicate that also the collagen-like proteins 
of subsp. equi can form this type of structures. 
 
The biological role of these proteins remains to be clarified. SclC was tested in a 
collagen lattice contraction study using mouse cells to see whether the protein had 
any effect on the contraction of the gels, which was found not to be the case. 
 
However, using sera from horses diagnosed with strangles it could be concluded 
that these proteins are most likely expressed during an infection of subsp. equi. 
Antibodies raised in a rabbit against one of the proteins, i.e. SclC, are cross-
reactive with the collagen-like region of the remaining six proteins, indicating that 
the antibodies formed after immunisations could be reactive against all collagen-
like proteins found in subsp. equi. This finding will be important if immunisation 
with SclC is protective in horses, since only one protein is needed in order to get 
antibodies reacting with all the collagen-like proteins from this subspecies.  
 
Immunisations with SclC in a strangles model in the mouse gave protection as 
measured by less weight loss and lower bacteria counts in vaccinated animals. 
Combining this protein with the other recombinant proteins (EAG and CNE) 
found to have a positive effect in the vaccination study would be interesting. This 
since these two recombinant proteins were found to enhance the rate of protection 
in combination with each other.  
 
In fact, the SclC protein has been introduced as a vaccine component in a horse 
vaccination trial including challenge. The results from this vaccination have not 
yet been fully evaluated, but the overall outcome looks promising. Consequently, 
further studies of the collagen-like proteins expressed by subsp. equi are needed in 
order to clarify their biological role and importance in virulence of this pathogenic 
bacterium. 
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